Literature DB >> 8198398

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

K J Tracey1, A Cerami.   

Abstract

Advances in the molecular biology of human diseases indicate that the most striking manifestations of illness may be caused not by exogenous pathogenic or tumor products, but rather by toxic peptides produced by the host itself. Tumor necrosis factor (TNF), a polypeptide cytokine produced during infection, injury, or invasion, has proved pivotal in triggering the lethal effects of septic shock syndrome, cachexia, and other systemic manifestations of disease. Because removing TNF from the diseased host may prevent development of the illness, this factor has recently been the focus of intensive research. This review discusses the biology of this cytokine, with particular emphasis on its potential therapeutic role in septic shock and cachexia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198398     DOI: 10.1146/annurev.med.45.1.491

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  216 in total

1.  Analysis of cytokine dynamics in corneal allograft rejection.

Authors:  C C Chan; J Stark; A J George
Journal:  Proc Biol Sci       Date:  1999-11-07       Impact factor: 5.349

2.  Rapid and sensitive assay of tumor necrosis factor-alpha gene transcription.

Authors:  X Zhang; J Ye; L Wang; J Manosroi; X Shi; Y Rojanasakul
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

3.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  [Do antisense oligonucleotides improve viral immunopathology?].

Authors:  S Wasmuth; D Bauer; K P Steuhl; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

Review 5.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 6.  Functional genomics of the murine immune system.

Authors:  H E Ruley
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo.

Authors:  S Endres; R E Whitaker; R Ghorbani; S N Meydani; C A Dinarello
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

8.  Ethyl pyruvate improves survival in awake hemorrhage.

Authors:  Bolin Cai; Michael Brunner; Haichao Wang; Ping Wang; Edwin A Deitch; Luis Ulloa
Journal:  J Mol Med (Berl)       Date:  2009-01-28       Impact factor: 4.599

9.  The Physiological Role of Tumor Necrosis Factor in Human Immunity and Its Potential Implications in Spinal Manipulative Therapy: A Narrative Literature Review.

Authors:  Liang Zhang; Chao Hua Yao
Journal:  J Chiropr Med       Date:  2016-05-26

10.  Tumor necrosis factor alpha enhances Actinobacillus actinomycetemcomitans leukotoxin-induced HL-60 cell apoptosis by stimulating lymphocyte function-associated antigen 1 expression.

Authors:  Noboru Yamaguchi; Chie Kubo; Yoshikazu Masuhiro; Edward T Lally; Toshihiko Koga; Shigemasa Hanazawa
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.